Clinical Trial Update: Fatty Acid Supplementation in Children With ASD (Study 2) [Phase 2]

View source ↗

Summary

Phase 2 trial results for fatty acid supplementation in children with autism spectrum disorder have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Omega-3 fatty acid supplementation (Omega-3 fatty acids)

Snippet

Sponsor: Sarah Keim | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-11-13